A DOUBLE-BLIND, PLACEBO-CONTROLLED CROSSOVER TRIAL OF 3,4 DIAMINOPYRIDINE IN THE SYMPTOMATIC TREATMENT OF MULTIPLE-SCLEROSIS

被引：0
|
作者：
CARTER, JL
STEVENS, JC
SMITH, B
CASELLI, RJ
METCALF, A
WINDEBANK, A
ZINSMEISTER, A
RODRIGUEZ, M
机构：
来源：
ANNALS OF NEUROLOGY | 1993年 / 34卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：272 / 273
页数：2
相关论文
共 50 条
  • [1] Treatment with oral 3,4 diaminopyridine improves leg strength in multiple sclerosis patients: Results of a randomized, double-blind, placebo-controlled, crossover trial
    Bever, CT
    Anderson, PA
    Leslie, J
    Panitch, HS
    DhibJalbut, S
    Khan, OA
    Milo, R
    Hebel, JR
    Conway, KL
    Katz, E
    Johnson, KP
    NEUROLOGY, 1996, 47 (06) : 1457 - 1462
  • [2] 3,4-diaminopyridine in childhood myasthenia: Double-blind, placebo-controlled trial
    Anlar, B
    Varli, K
    Ozdirim, E
    Ertan, M
    JOURNAL OF CHILD NEUROLOGY, 1996, 11 (06) : 458 - 461
  • [3] A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF TIZANIDINE IN THE TREATMENT OF SPASTICITY CAUSED BY MULTIPLE-SCLEROSIS
    BARNES, MP
    BATES, D
    CORSTON, RN
    CROWDER, D
    DICK, DJ
    EMRE, M
    FINDLEY, LJ
    WOOD, H
    HAWKES, CH
    HAWKINS, SA
    HUDGSON, P
    KENDALL, F
    JEWITT, K
    MOFFAT, B
    MILLAC, P
    PARK, D
    PERKIN, GD
    ROBERTS, R
    SAGAR, H
    SPOKES, E
    NEUROLOGY, 1994, 44 (11) : 70 - 78
  • [4] TIZANIDINE TREATMENT OF SPASTICITY CAUSED BY MULTIPLE-SCLEROSIS - RESULTS OF A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    SMITH, C
    BIRNBAUM, G
    CARTER, JL
    GREENSTEIN, J
    LUBLIN, FD
    BAUMEL, B
    HSU, CY
    MURPHY, F
    READER, AT
    SCHAPIRO, RT
    SIBLEY, WA
    STAZIO, A
    TROTTER, JL
    VOLLMER, TL
    WALSHE, TM
    NEUROLOGY, 1994, 44 (11) : 34 - 43
  • [5] HYPERBARIC-OXYGEN AND MULTIPLE-SCLEROSIS, RESULTS OF A PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL
    BARNES, MP
    BATES, D
    CARTLIDGE, NEF
    FRENCH, DM
    SHAW, DA
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1986, 49 (06): : 730 - 730
  • [6] A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF INFLUENZA IMMUNIZATION IN MULTIPLE-SCLEROSIS
    MILLER, AE
    MORGANTE, LA
    BUCHWALD, LY
    NUTILE, SM
    COYLE, PK
    KRUPP, LB
    DOSCHER, CA
    LUBLIN, FD
    KNOBLER, RL
    TRANTAS, F
    KELLEY, L
    SMITH, CR
    LAROCCA, N
    LOPEZ, S
    NEUROLOGY, 1995, 45 (04) : A436 - A436
  • [7] THE EFFECTS OF 4-AMINOPYRIDINE IN MULTIPLE-SCLEROSIS PATIENTS - RESULTS OF A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, CONCENTRATION-CONTROLLED, CROSSOVER TRIAL
    BEVER, CT
    YOUNG, D
    ANDERSON, PA
    KRUMHOLZ, A
    CONWAY, K
    LESLIE, J
    EDDINGTON, N
    PLAISANCE, KI
    PANITCH, HS
    DHIBJALBUT, S
    FOSSLER, MJ
    DEVANE, J
    JOHNSON, KP
    NEUROLOGY, 1994, 44 (06) : 1054 - 1059
  • [8] DOUBLE-BLIND, CONTROLLED TRIAL OF IMMUNOSUPPRESSION IN TREATMENT OF MULTIPLE-SCLEROSIS
    MERTIN, J
    KNIGHT, SC
    RUDGE, P
    THOMPSON, EJ
    HEALY, MJR
    LANCET, 1980, 2 (8201): : 949 - 951
  • [9] DOUBLE-BLIND CONTROLLED TRIAL OF AZATHIOPRINE IN THE TREATMENT OF MULTIPLE-SCLEROSIS
    不详
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1987, 50 (10): : 1387 - 1387
  • [10] OUTCOME MEASURES IN RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND MULTIPLE-SCLEROSIS CLINICAL-TRIAL
    NOSEWORTHY, JH
    OBRIEN, PC
    NAESSENS, JM
    NEUROLOGY, 1994, 44 (04) : A392 - A392
12345